Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Can Big Tech help to de-risk personalized medicine?

Can Big Tech help to de-risk personalized medicine?

FromPharma Unlimited


Can Big Tech help to de-risk personalized medicine?

FromPharma Unlimited

ratings:
Length:
28 minutes
Released:
Dec 1, 2021
Format:
Podcast episode

Description

In the first episode of our Pharma Unlimited podcast, host Bertrand Bodson and Dr. Peter Lee, Corporate Vice President of Research and Incubation at Microsoft Healthcare, discuss the role Big Tech can play in reducing risk in medicine. This episode looks at the different mindsets between the tech and pharma industries coming together, across the value of intellectual property and more.
Released:
Dec 1, 2021
Format:
Podcast episode

Titles in the series (5)

Welcome to Pharma Unlimited, by Wolters Kluwer. Join host Bertrand Bodson as we go under the microscope to examine some of the biggest issues facing the pharma sector. What will the arrival of Big Tech mean for innovation, risk, and regulation? How will the industry develop new treatments in a post-pandemic world? This five-part series will feature some of the leading lights in life sciences and technology and explore some of the biggest questions facing the pharma industry.